Sagent Pharmaceuticals , Nasdaq: SGNT
Markets generic injectable drugs to the hospital market.
Industry: Health Care
First Day Return: +24.4%
| IPO Data | |
|---|---|
| IPO Date | 04/19/2011 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $92 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Schaumburg, IL, United States |
| Founded | 2006 |
| Employees at IPO | 84 |
| Website www.sagentpharma.com | |
Sagent Pharmaceuticals (SGNT) Performance
